Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Inventory (2020 - 2025)

Rapid Micro Biosystems' Inventory history spans 6 years, with the latest figure at $17.6 million for Q4 2025.

  • On a quarterly basis, Inventory fell 12.91% to $17.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $17.6 million, a 12.91% decrease, with the full-year FY2025 number at $17.6 million, down 12.91% from a year prior.
  • Inventory hit $17.6 million in Q4 2025 for Rapid Micro Biosystems, down from $21.1 million in the prior quarter.
  • Over the last five years, Inventory for RPID hit a ceiling of $21.4 million in Q2 2024 and a floor of $11.9 million in Q2 2021.
  • Historically, Inventory has averaged $19.4 million across 5 years, with a median of $20.6 million in 2025.
  • Biggest five-year swings in Inventory: soared 78.78% in 2022 and later decreased 12.91% in 2025.
  • Tracing RPID's Inventory over 5 years: stood at $15.7 million in 2021, then surged by 35.2% to $21.2 million in 2022, then decreased by 5.79% to $20.0 million in 2023, then grew by 1.2% to $20.2 million in 2024, then decreased by 12.91% to $17.6 million in 2025.
  • Business Quant data shows Inventory for RPID at $17.6 million in Q4 2025, $21.1 million in Q3 2025, and $20.6 million in Q2 2025.